MTD Group Acquires Ypsomed's Pen Needles and Blood Glucose Monitoring Businesses

Marketlab Acquires Assets of Medi‑Tech International Corporation

September 12, 2023

Medical Devices

Marketlab, a family-owned manufacturer of specialty healthcare products based in Caledonia, Michigan, has acquired the assets of Medi‑Tech International Corporation, a Brooklyn, New York‑based manufacturer of wound care, labor‑and‑delivery, and patient safety products. The acquisition expands Marketlab’s medical‑surgical and laboratory product portfolio and brings additional products, distribution partnerships, and GPO contracts into its offering to better serve IDNs and other healthcare customers.

Abbott Acquires Bigfoot Biomedical

September 5, 2023

Medical Devices

Abbott has entered a definitive agreement to acquire Bigfoot Biomedical, a developer of smart insulin management systems that integrate continuous glucose monitoring with connected insulin pen caps and a cloud-based provider portal. The acquisition will combine Abbott’s FreeStyle Libre CGM technology with Bigfoot’s dosing-capable pen cap platform to further develop personalized, connected diabetes care solutions; the deal is expected to close in Q3 2023 and financial terms were not disclosed.

Molded Devices (MDI) Acquires GlobalMed's Medical Tubing Operations from Schauenburg

November 9, 2022

Medical Devices

Molded Devices, Inc. (MDI), majority‑owned by TruArc Partners, acquired GlobalMed Inc. (Canada) and Schauenburg‑Truplast (China) from Schauenburg Hose Technology. The deal expands MDI’s extrusion and tubing capabilities for medical device OEMs, adding GlobalMed’s Canadian and Chinese production footprint and management team to MDI’s global manufacturing platform. Financial terms were not disclosed.

Tandem Diabetes Care Acquires Capillary Biomedical

July 21, 2022

Medical Devices

Tandem Diabetes Care, Inc. has acquired Capillary Biomedical, a developer of extended-wear insulin infusion set technology. The acquisition (terms not disclosed) brings Capillary's infusion-set R&D into Tandem's product portfolio to expand infusion set options and advance extended-wear solutions for insulin pump users.

Novaremed AG Acquires Metys Pharmaceuticals AG

September 7, 2021

Pharmaceuticals

Novaremed AG acquired Metys Pharmaceuticals AG in an all-share transaction, integrating Metys' clinical and preclinical non-opioid pain programs (including MP-101 and MP-103) into Novaremed's pipeline. The deal broadens Novaremed's focus from painful diabetic peripheral neuropathy (PDPN) to include chemotherapy-induced peripheral neuropathy (CIPN) and strengthens leadership with the election of Andrew J. Oakley to Novaremed's board.

Theragenics Corporation Acquires NeedleTech Products, Inc.

July 28, 2008

Medical Devices

Theragenics Corporation (NYSE: TGX) completed the acquisition of NeedleTech Products, Inc. on July 28, 2008 for $47.8 million in cash. NeedleTech, a specialty-needle and medical-device manufacturer based in Attleboro, Massachusetts with 2007 revenue of $16.9 million, will be consolidated into Theragenics' surgical products segment immediately; Theragenics financed part of the purchase with $24.5 million borrowed on its existing credit facility.